Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre’s readiness in United States and EU

23 Apr 2021

Abstract excerpt

Comprehensive, integrated care provided by a multi-disciplinary team of experts improves outcomes and is widely recommended for people with haemophilia (PWH).1-6 Although care models vary, the principles of management are consistent between countries. The likely approval of gene therapy for PWH in the next few years has the potential to alter the course of disease and drive an evolution in haemophilia care.7, 8 A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to CAR-T cell therapy research
Share to Hemophilia Treatment and Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33892516
DOI: 10.1111/hae.14309

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre’s readiness in United States and EUPMID 33892516Read ↗

Transforming Hemophilia Management: Lessons from Gene Therapy Clinical TrialsSemantic proximity Read ↗

The 1st WFH Gene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the worldSemantic proximity Read ↗

Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHCSemantic proximity Read ↗

Gene therapy in hemophilia: the dawn of a new eraSemantic proximity Read ↗

The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies.Semantic proximity Read ↗

The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the artSemantic proximity Read ↗

The Arrival of Gene Therapy for Patients with Hemophilia ASemantic proximity Read ↗

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and ChallengesSemantic proximity Read ↗

Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomesSemantic proximity Read ↗

Hemophilia gene therapy comes of ageSemantic proximity Read ↗

Researchers welcome $3.5-million haemophilia gene therapy — but questions remainSemantic proximity Read ↗

Hemophilia gene therapy comes of ageSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.